Last Price
15.36
Today's Change
+0.065 (0.42%)
Day's Change
15.17 - 15.73
Trading Volume
20,144
Overview
Market Cap
101 Million
Shares Outstanding
6 Million
Avg Volume
84,052
Avg Price (50 Days)
18.83
Avg Price (200 Days)
24.47
PE Ratio
-1.36
EPS
-11.39
Earnings Announcement
08-May-2025
Previous Close
15.30
Open
15.28
Day's Range
15.17 - 15.98
Year Range
9.62 - 92.0
Trading Volume
36,133
Price Change Highlight
1 Day Change
1.01%
5 Day Change
-3.89%
1 Month Change
-13.61%
3 Month Change
-21.19%
6 Month Change
-55.72%
Ytd Change
-28.52%
1 Year Change
44.30%
3 Year Change
-90.83%
5 Year Change
-97.08%
10 Year Change
-97.08%
Max Change
-97.08%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
.png)
Apps
Top Articles
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
